Your browser doesn't support javascript.
loading
PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer.
Li, Xinwei; Fan, Yongfei; Tang, Mingyue; Li, Huiyuan; Zhang, Yue; Mi, Jiaqi; Wang, Yanyan; Zhao, Menglin; Wang, Zishu; Su, Fang.
Afiliación
  • Li X; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
  • Fan Y; Department of Thoracic Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, People's Republic of China.
  • Tang M; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
  • Li H; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
  • Zhang Y; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
  • Mi J; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
  • Wang Y; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
  • Zhao M; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
  • Wang Z; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
  • Su F; Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China.
J Inflamm Res ; 15: 5439-5455, 2022.
Article en En | MEDLINE | ID: mdl-36147688

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Inflamm Res Año: 2022 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Inflamm Res Año: 2022 Tipo del documento: Article Pais de publicación: Nueva Zelanda